The antimicrobial activity of Physalis peruviana L.

In this study, the antimicrobial activity of Physalis peruviana L. was investigated. The antimicrobial activity was evaluated according to the microdilution method by using Bacillus megaterium DMS 32, Pseudomonas aeruginosa DMS 50071, Escherichia coli ATCC 25922, Klebsiella pneumoniae FMC 5, Proteus vulgaris FMC 1, Enterobacter aeregenes CCM 2531, Candida albicans FMC 17, Candida globrata ATCC 66032, Candida tropicalis ATCC 13803, Trichophyton sp. and Epidermaphyton sp. In the end of experimental studies, the fruit juice extract of P. peruviana was inhibited the growth of microorganisms used in the test at different ration. MIC values of fruit juice was determined as 3.125- 25 µl.

Keywords:

Antimicrobial activity, P. peruviana medicinal plant, test microorganisms,

PDF

___

Anonymous (1993). Summary of WHO (World Health Organisation) guidelines for the assesment of herbal medicines. Gram 28, 13-14.
Ateş A, Erdoğrul OT (2003). Antimicrobial activities of various medicinal and commercial plant extracts. Turk J Biol 27, 157-162.
Baker JT, Borris RP, Carte B (1995). Natural product drug discovery and development. New perpective on international collaboratin. J Nat Prod 58, 1325-1325.
Baytop T (1984). Türkiye bitkileri ile tedavi. İÜ Yayınları, 3255 Ecz. Fak. No: 40.
Chiang HC, Jaw SM, Chen PM (1992). Inhibitory effects of physalin B and physalin F on various human leukemia cells in vitro. Anticancer Res 12, 1155–1162.
Dulger B, Gonuz A, Bican T (2005). Antimicrobial studies on three endemic species of Sideritis from Turkey. Acta Biol Cracov Bot 47, 153-156.
Helvaci S, Kokdil G, Kawai M, Duran N, Duran G, Guvenc A (2010). Antimicrobial activity of the extracts and physalin D from Physalis alkekengi and evaluation of antioxidant potential of physalin D. Pharm Biol 48, 142-15
Kirbag S, Kurşat M, Zengin FK (2005). Elazığ’da tıbbi amaçlar için kullanılan bazı bitki extraktlarının anti- mikrobiyal aktiviteleri. Doğu Anadolu Bölgesi Araştırmaları 168-171.
Kivcak B, Mert T, Ozturk HT (2002). Antimicrobial and cytotoxic activities of Cerratonia siliqua L. extracts. Turk J Biol 26, 197-200.
Kumar PV, Chauhan SN, Padh H, Rajani M (2006 ). Search for antibacterial and antifungal agents from selected Indian medicinal plants. J Ethnopharmacol 107, 182- 188.
Magalhaes HI, Veras ML, Torres MR, et al. (2006). In- vitro and in-vivo antitumor activity of physalins B and D from Physalis angulata. J Pharm Pharmaco 58.
Mahansen A, Abbas M (1996). Antimicrobial activity of extracts of extracts of herbal plants used traditional medicine of Bahrain. Phytother Res 10, 251-253. in the
Mathabe MC , Nikolova RV, Laly N, Nyzema NZ (2006). Antibacterial activities of medicinal plants used for the treatment of diarrhoea in Limpopo Province, South Africa. J Ethnopharmacol 107, 286-293.
Nair R, Kalariye T, Chanda S (2005). Antimicrobial Activity of some selected Indian Medicinal Flora. Turk J Biol 29, 41-47.
NCCLS (2000). Methods for Dilution and Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobicall; Approved Standard-Fifth Edition. NCCLS document M7-A5, NCCLS: Wayne, PA, USA.
Osho A, Adetunji T, Fayemi SO, Moronkola DO (2010) . Antimicrobial Activity Of Essential Oils Of Physalis angulata. L. Afr J Tradit Complem 7, 303-306.
Parekh J, Chanda S (2007). In vitro antimicrobial activity of Trapa natans L. fruit rind extracted in different solvents . Afr J Biotech 6, 766-770.
Sengul M, Ogutçu H, Adiguzel A, et al. (2005). Anti- microbial effects of Verbascum georgicum bentham extract. Turk J Biol 29, 105-110.
Soares MB, Bellintani MC, Ribeiro IM, et al. (2003). Inhibition of macrophage activation and lipopoly- saccaride-induced death by seco-steroids from Physalis angulata L. Eur. J. Pharmacol 459, 107– 112. purified
Uzun Y, Keles A, Imali A, Ogun E, Kaya A (2002). Antimicrobial activity of Urtica dioica L. and ribes L. Biosci Res Bull 18, 43-50. Rheum
Vieria AT, Pinho V, Lepsch LB, Scavone C, et al. (2005). Mechanisms of the anti-inflammatory effects of the natural secosteroids physalins in a model of intestinal ischaemia and reperfusion injury. Brit J Pharmacol 146, 244–251.